 |
autologus CD34+ cells transfected with retroviral vector containing adenosine deaminase gene |
|---|---|
| Trade Name | |
| Orphan Indication | Severe combined immunodeficiency |
| USA Market Approval | USA |
| USA Designation Date | 2009-08-26 00:00:00 |
| Sponsor | Glaxo Group Limited;I-3 Iron Bridge Road, Stockley Park West; |
